Novartis AG (NVS) NYSE
145.68
-4.49(-2.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
145.68
-4.49(-2.99%)
Currency In USD
| Market Cap | 267.32B |
| Enterprise Value | 292.92B |
| P/E Ratio | 20.5 |
| PEG Ratio | 2.4 |
| Price/Sales Ratio | 4.98 |
| Price/Book Ratio | 7.16 |
| Enterprise/Revenue | 5.71 |
| Enterprise/EBITDA | 14.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.24 |
| Operating Margin | 0.3 |
| Return On Assets | 0.11 |
| Return On Equity | 0.32 |
| Revenue | 54.81B |
| Revenue/Share | 29.05 |
| Gross Profit | 41.12B |
| EBITDA | 22.99B |
| Net Income | 14.06B |
| Diluted EPS | 7.19 |
| Total Cash | 6.98B |
| Total Cash/Share | 3.67 |
| Total Debt | 47B |
| Total Debt/Equity | 1.22 |
| Current Ratio | 0.85 |
| Book Value Per Share | 20.45 |
| 52-Week Change | 24.83 |
| 52-Week High | 170.46 |
| 52-Week Low | 112.34 |
| Moving Average 50 Days | 149.51 |
| Moving Average 200 Days | 140.61 |
| Average Volume | 1.74M |
| Shares Outstanding | 1.91B |
| % Held by Institutions | 7.54 |
| Trailing Annual Dividend Rate | 4.7 |
| Trailing Annual Dividend Yield | 3.25 |
| Payout Ratio | 0.61 |
| Last Split Factor | 279:250 |
| Last Split Date | April 09, 2019 |